I especially like this section of the press release:
BioLife will be exhibiting and presenting at the annual meeting of the International Society for Stem Cell Research on June 17-21, 2007, in Cairns, Australia, and, several days later on June 24-27, the annual meeting of the International Society for Cellular Therapy, in Sydney, Australia.
I also liked the projected growth for the niche market that they are in. $175 million to $300 million in next 4 years. I also anticipate that the company will be getting FDA approval for other products down the line, which will open up the markets even further.